Physician profile
David J O'Connor
NPI 1063736510
$271,661.99
in general payments reported to CMS, 2019-2025
41 companies · $40K in 2025
The $40K reported for 2025 was more than what 97% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $60K · 2020: $32K · 2021: $44K · 2022: $28K · 2023: $22K · 2024: $44K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $75K · Food and Beverage: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Travel and Lodging: $3,432 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $74,928.03 |
| Food and Beverage | $13,223.92 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,100.00 |
| Travel and Lodging | $3,431.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,240.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $74,999.03 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Terumo Medical Corporation | $27,497.83 | 2019-2025 | Metacross Otw, Glidesheath Slender, Glidewire |
| Cardiovascular Systems INC. | $22,764.12 | 2019-2022 | |
| Philips North America LLC | $18,854.91 | 2019-2025 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided, Igt Devices Undivided |
| Bard Peripheral Vascular, INC. | $15,619.43 | 2019-2025 | Fluency Endovascular Stent Graft, Rotarexs 6 F X 135 Cm, Denali Vena Cava Filter |
| Cagent Vascular INC | $15,223.12 | 2024-2025 | Serrantor |
| Bolton Medical INC | $15,126.57 | 2022-2024 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Contego Medical, INC | $14,948.99 | 2024-2025 | Neuroguard Direct |
| Shockwave Medical, INC | $13,073.81 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Siemens Medical Solutions USA, INC. | $8,353.34 | 2019 | |
| Abbott Laboratories | $8,233.16 | 2019-2024 | Diamondback Peripheral, Jeti Peripheral Catheter, Pressurewire |
| Inquis Medical, INC. | $7,905.61 | 2024-2025 | Aventus |
| Penumbra, INC. | $5,086.93 | 2019-2025 | Indigo System, Penumbra System, Ruby Coil |
| Endologix LLC | $3,632.43 | 2024-2025 | Endocross Device, Torus Stent Graft System, Afx2 Bifurcated Endograft System |
| Boston Scientific Corporation | $3,510.61 | 2019-2025 | 2cm Peripheral Cutting Balloon, Eluvia, Interlock |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,097.87 | 2021-2025 | Hawkone, Abre, Pacific Xtreme |
| Integra Lifesciences Corporation | $2,400.00 | 2022 | |
| Reflow Medical INC | $2,203.84 | 2024-2025 | |
| Surmodics, INC. | $1,610.17 | 2023-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Globus Medical, INC. | $1,553.55 | 2020 | |
| W. L. Gore & Associates, INC. | $1,489.40 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Cook Medical LLC | $1,075.93 | 2019-2024 | Zenith Spiral-Z, Zenith, Advance |
| Inari Medical, INC. | $1,075.80 | 2020-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $662.13 | 2019-2020 | |
| Saranas, INC. | $281.75 | 2023 | |
| Cvrx, INC. | $246.29 | 2020-2025 | Barostim Neo System |
| Acera Surgical, INC. | $198.91 | 2021-2022 | |
| Cardiva Medical, INC. | $167.50 | 2022 | |
| Janssen Pharmaceuticals, INC | $144.05 | 2019-2021 | |
| Organogenesis INC. | $139.79 | 2025 | Nushield, Apligraf |
| Veryan Medical Incorporated | $134.47 | 2022 | |
| Checkpoint Surgical, INC | $96.04 | 2022 | |
| Angiodynamics, INC. | $66.00 | 2021-2024 | Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Lemaitre Vascular, INC. | $58.81 | 2022-2024 | Artegraft Vascular Graft |
| Tactile Systems Technology INC | $34.52 | 2020 | |
| Argon Medical Devices, INC. | $27.29 | 2021 | |
| Bioventus LLC | $20.15 | 2022 | |
| Ge Healthcare | $18.79 | 2022 | |
| Advanced Oxygen Therapy INC. | $14.71 | 2023 | Topical Oxygen Chamber For Extremities |
| Merit Medical Systems INC | $14.34 | 2025 | Swiftninja Steerable Microcatheter, Merit Mak Kits |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$30,830.62 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David O'Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.